Study of a new drug for patients with solid tumors
Part of Cancer clinical trials.
This trial tests a new drug, SHR-4685, for people with solid tumors that are measurable. It aims to see if the drug is safe and how your body processes it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old
- You have a solid tumor that can be seen on scans
- You have not had cancer treatment (including other study drugs) in the last 4 weeks
- You are in fairly good health, able to care for yourself, and expected to live more than 3 months
- You do not have certain conditions like active infections, blood clots, or tumors that have spread to the brain
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called SHR-7367 combined with other cancer medicines for people with solid tumors. It aims to see if the combination is safe and effective.
This study tests a new drug called SHR-9839 given under the skin, combined with other anti-cancer treatments, for people with solid tumors. The goal is to see if it is safe and effective.
This trial tests a new drug called SHR-4602, alone or with other cancer treatments, for people with advanced solid tumors that have HER2 protein. It may be an option if you have already tried standard therapies and your cancer is still growing.
This study tests a new drug called SHR-8203 for people with advanced solid tumors that have stopped responding to standard treatments or have no treatment options. The goal is to see if the drug is safe and helps shrink or control the tumor.
This trial tests a new drug called SHR-4610 for people with advanced solid tumors that have not responded to standard treatments. It aims to see if the drug is safe and effective, and may be an option if you have a measurable tumor and are generally in good health.
This study tests a new experimental drug, SHR-4375, for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if the drug is safe and effective for these cancers.
Hear when a new Solid Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.